Currently Browsing: Dangerous Products

Filing a Xarelto Lawsuit

There are currently 240% more patients who have been put on or switched to Xarelto (rivaroxaban), the once-daily anticoagulant medication in 2013 as compared to 2012. It was approved by the Food and Drug Administration for the management of atrial fibrillation and deep vein thrombosis (DVT) in July 2011. It is also prescribed as a prophylaxis after hip or knee replacement surgery. Xarelto is supposed to be an improvement over warfarin as the standard anticoagulation drug.

That’s all well and good, but then the complaint started coming in.

The first lawsuit against Xarelto for uncontrollable bleeding was filed by a woman in Kentucky in February 2014 and more have trickled in, but it is speculated that Xarelto may well follow the pattern set by its Boehringer Ingersoll rival Pradaxa, also an anticoagulant with product liability problems. The big problem of US distributor Janssen Pharmaceuticals, a division of Johnson & Johnson, is that the claims against Xarelto are that it is too dangerous to be sold at all. This is in the wake of the Supreme Court ruling acknowledging the liability of pharmaceutical companies for injuries or deaths caused by products proven to have too high a risk for patients.

Filing a Xarelto lawsuit at this junction may not be so easy, as xarelto lawsuit lawyers at the National Injury Law Center are some of the few that have the experience and knowledge to pull it off. However, if you suspect that your injuries may be due to Xarelto, it would be worth it to take the trouble to consult with one of them just to get an idea of what to expect.

Most reputable personal injury lawyers offer free initial consultation, and many only take on cases they can win because they only get paid if they do; this is called on a contingent fee basis. If this is what is offered to you, you can be sure that you aren’t wasting your time in pursuing a case that has no merit.